Skip to main content
. Author manuscript; available in PMC: 2018 Jan 29.
Published in final edited form as: Biochem Biophys Res Commun. 2016 Dec 24;483(1):258–263. doi: 10.1016/j.bbrc.2016.12.156

Figure 2. [64Cu]WL12 shows specificity to PD-L1 in vitro.

Figure 2

A, Competitive inhibition assay demonstrating the affinity of WL12 analogs for inhibiting PD-1:PD-L1 interaction; B, Flow cytometry histograms of cell lines used for in vitro studies show variable PD-L1 expression, BD-MIH1-PE is phycoerythryn conjugated anti human PD-L1 antibody; C, [64Cu]W12 shows increased binding to cells with high PD-L1 expression which could be blocked by excess peptide (PEP). Significance is indicated by asterisks (*) and the comparative reference is uptake by cell line with low PD-L1 expression or uptake at the blocking dose. ***P < 0.001.

HHS Vulnerability Disclosure